| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44 |
| filingDate |
1986-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1992-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1992-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0196769-B1 |
| titleOfInvention |
A novel transdermal pharmaceutical absorption dosage unit |
| abstract |
A novel transdermal pharmaceutical polymer matrix dosage unit is provided which comprises a backing layer, an adjoining layer of a solid polymer matrix in which the pharmaceutical is microdispersed and a final biologically acceptable adhesive polymer layer which has dispersed therein a skin permeation enhancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8754070-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8741881-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9125816-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9132089-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8466136-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2934162-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8466138-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8466137-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010010240-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8729057-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8759329-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486925-B2 |
| priorityDate |
1985-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |